What does this research mean for the field?

Aspirin significantly reduces uterine artery blood flow resistance in patients with recurrent pregnancy loss, but the addition of low molecular weight heparin (LMWH) provides no synergistic effect compared to aspirin alone. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate how aspirin alone versus aspirin combined with low molecular weight heparin alters uterine artery blood flow parameters across pregnancy in patients with recurrent pregnancy loss.

September 8, 2026BMC Pregnancy and ChildbirthOpen Access

Effects of aspirin and low molecular weight heparin on uterine artery blood flow in patients with recurrent pregnancy loss: an observational study

View Full Paper

Ask AI

Bookmark

To evaluate how aspirin alone versus aspirin combined with low molecular weight heparin alters uterine artery blood flow parameters across pregnancy in patients with recurrent pregnancy loss.
Observational study enrolling 175 participants stratified into an aspirin group (n=54), an aspirin plus low molecular weight heparin group (n=81), and a control group without miscarriage history (n=40).
Doppler ultrasonography measured uterine artery pulsatility index, resistive index, and systolic-to-diastolic ratios in the midluteal phase (including after two months of aspirin) and periodically through 32 weeks of gestation.
Baseline midluteal pulsatility index, resistive index, and systolic-to-diastolic ratios were significantly higher in recurrent pregnancy loss cohorts compared with controls (P < 0.001), but all parameters significantly declined following aspirin treatment (P < 0.001).
Hemodynamic resistance progressively declined across gestation in all groups (P < 0.001), with no significant differences detected between the aspirin-only and combination therapy groups at any evaluated gestational stage (P > 0.05).

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational study reveals aspirin reduces uterine artery resistance in recurrent pregnancy loss, indicating low molecular weight heparin provides no additional vascular benefit.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd82058e84d0ff5b4754b https://doi.org/10.1186/s12884-026-09904-6

View Full Paper

Ask AI

Bookmark

Implication

Observational study reveals aspirin reduces uterine artery resistance in recurrent pregnancy loss, indicating low molecular weight heparin provides no additional vascular benefit.

Effects of aspirin and low molecular weight heparin on uterine artery blood flow in patients with recurrent pregnancy loss: an observational study

Key Points

Discussion

Implication

Cite This Study

Effects of aspirin and low molecular weight heparin on uterine artery blood flow in patients with recurrent pregnancy loss: an observational study

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider